|
🦁
|
Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease
15 auth.
Luke Whiley,
Arundhuti Sen,
James C. Heaton,
P. Proitsi,
D. García-Gómez,
Rufina Leung,
N. Smith,
M. Thambisetty,
I. Kloszewska,
P. Mecocci,
...
H. Soininen,
M. Tsolaki,
B. Vellas,
S. Lovestone,
C. Legido-Quigley
|
8 |
2014 |
8
🦁
|
|
🐜
|
Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis
16 auth.
P. Proitsi,
Min Kim,
Luke Whiley,
A. Simmons,
M. Sattlecker,
L. Velayudhan,
Michelle K. Lupton,
Hillka Soininen,
I. Kloszewska,
P. Mecocci,
...
M. Tsolaki,
B. Vellas,
S. Lovestone,
J. Powell,
R. Dobson,
C. Legido-Quigley
|
7 |
2017 |
7
🐜
|
|
🐜
|
Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease
15 auth.
P. Proitsi,
Min Kim,
Luke Whiley,
M. Pritchard,
Rufina Leung,
H. Soininen,
I. Kloszewska,
P. Mecocci,
M. Tsolaki,
B. Vellas,
...
P. Sham,
S. Lovestone,
J. Powell,
Richard J. B. Dobson,
C. Legido-Quigley
|
6 |
2015 |
6
🐜
|
|
🦁
|
In-vial dual extraction for direct LC-MS analysis of plasma for comprehensive and highly reproducible metabolic fingerprinting.
Luke Whiley,
Joanna Godzień,
F. J. Rupérez,
C. Legido-Quigley,
C. Barbas
|
6 |
2012 |
6
🦁
|
|
🐜
|
Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer’s Disease
18 auth.
Min Kim,
A. Nevado-Holgado,
Luke Whiley,
S. Snowden,
H. Soininen,
I. Kloszewska,
P. Mecocci,
M. Tsolaki,
B. Vellas,
M. Thambisetty,
...
R. Dobson,
J. Powell,
Michelle K. Lupton,
A. Simmons,
L. Velayudhan,
S. Lovestone,
P. Proitsi,
C. Legido-Quigley
|
6 |
2016 |
6
🐜
|
|
🦁
|
Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease
16 auth.
Luke Whiley,
Katie E. Chappell,
E. D'Hondt,
M. Lewis,
B. Jiménez,
S. Snowden,
H. Soininen,
I. Kloszewska,
P. Mecocci,
M. Tsolaki,
...
B. Vellas,
J. Swann,
Abdul Hye,
S. Lovestone,
C. Legido-Quigley,
E. Holmes
|
6 |
2021 |
6
🦁
|
|
🐜
|
Urinary metabolic phenotyping for Alzheimer’s disease
27 auth.
N. Kurbatova,
Manik Garg,
Luke Whiley,
E. Chekmeneva,
B. Jiménez,
María Gómez-Romero,
J. Pearce,
Torben Kimhofer,
E. D'Hondt,
H. Soininen,
I. Kloszewska,
P. Mecocci,
M. Tsolaki,
B. Vellas,
D. Aarsland,
...
A. Nevado-Holgado,
B. Liu,
S. Snowden,
P. Proitsi,
N. Ashton,
Abdul Hye,
C. Legido-Quigley,
M. Lewis,
J. Nicholson,
E. Holmes,
A. Brazma,
S. Lovestone
|
5 |
2020 |
5
🐜
|
|
🐬
|
In-vial dual extraction liquid chromatography coupled to mass spectrometry applied to streptozotocin-treated diabetic rats. Tips and pitfalls of the method.
Joanna Godzień,
M. Ciborowski,
Luke Whiley,
C. Legido-Quigley,
F. J. Rupérez,
C. Barbas
|
4 |
2013 |
4
🐬
|
|
🦁
|
Current strategies in the discovery of small-molecule biomarkers for Alzheimer's disease.
Luke Whiley,
C. Legido-Quigley
|
4 |
2011 |
4
🦁
|
